These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


516 related items for PubMed ID: 25372750

  • 1. CXCL14 antagonizes the CXCL12-CXCR4 signaling axis.
    Hara T, Tanegashima K.
    Biomol Concepts; 2014 May; 5(2):167-73. PubMed ID: 25372750
    [Abstract] [Full Text] [Related]

  • 2. CXCL14 is a natural inhibitor of the CXCL12-CXCR4 signaling axis.
    Tanegashima K, Suzuki K, Nakayama Y, Tsuji K, Shigenaga A, Otaka A, Hara T.
    FEBS Lett; 2013 Jun 19; 587(12):1731-5. PubMed ID: 23669361
    [Abstract] [Full Text] [Related]

  • 3. Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4.
    Collins PJ, McCully ML, Martínez-Muñoz L, Santiago C, Wheeldon J, Caucheteux S, Thelen S, Cecchinato V, Laufer JM, Purvanov V, Monneau YR, Lortat-Jacob H, Legler DF, Uguccioni M, Thelen M, Piguet V, Mellado M, Moser B.
    FASEB J; 2017 Jul 19; 31(7):3084-3097. PubMed ID: 28360196
    [Abstract] [Full Text] [Related]

  • 4. Dimeric peptides of the C-terminal region of CXCL14 function as CXCL12 inhibitors.
    Tanegashima K, Tsuji K, Suzuki K, Shigenaga A, Otaka A, Hara T.
    FEBS Lett; 2013 Nov 29; 587(23):3770-5. PubMed ID: 24161674
    [Abstract] [Full Text] [Related]

  • 5. CXCL14 is no direct modulator of CXCR4.
    Otte M, Kliewer A, Schütz D, Reimann C, Schulz S, Stumm R.
    FEBS Lett; 2014 Dec 20; 588(24):4769-75. PubMed ID: 25451233
    [Abstract] [Full Text] [Related]

  • 6. CXCL14-CXCR4 and CXCL12-CXCR4 Axes May Play Important Roles in the Unique Invasion Process of Endometrioid Carcinoma With MELF-Pattern Myoinvasion.
    Kojiro-Sanada S, Yasuda K, Nishio S, Ogasawara S, Akiba J, Ushijima K, Yano H.
    Int J Gynecol Pathol; 2017 Nov 20; 36(6):530-539. PubMed ID: 28277316
    [Abstract] [Full Text] [Related]

  • 7. CXCL14 Preferentially Synergizes With Homeostatic Chemokine Receptor Systems.
    Kouzeli A, Collins PJ, Metzemaekers M, Meyrath M, Szpakowska M, Artinger M, Struyf S, Proost P, Chevigne A, Legler DF, Eberl M, Moser B.
    Front Immunol; 2020 Nov 20; 11():561404. PubMed ID: 33123134
    [Abstract] [Full Text] [Related]

  • 8. Comparative expression pattern analysis of the highly conserved chemokines SDF1 and CXCL14 during amniote embryonic development.
    García-Andrés C, Torres M.
    Dev Dyn; 2010 Oct 20; 239(10):2769-77. PubMed ID: 21038449
    [Abstract] [Full Text] [Related]

  • 9. Trafficking of normal stem cells and metastasis of cancer stem cells involve similar mechanisms: pivotal role of the SDF-1-CXCR4 axis.
    Kucia M, Reca R, Miekus K, Wanzeck J, Wojakowski W, Janowska-Wieczorek A, Ratajczak J, Ratajczak MZ.
    Stem Cells; 2005 Aug 20; 23(7):879-94. PubMed ID: 15888687
    [Abstract] [Full Text] [Related]

  • 10. Fluorescent CXCL12AF647 as a novel probe for nonradioactive CXCL12/CXCR4 cellular interaction studies.
    Hatse S, Princen K, Liekens S, Vermeire K, De Clercq E, Schols D.
    Cytometry A; 2004 Oct 20; 61(2):178-88. PubMed ID: 15382150
    [Abstract] [Full Text] [Related]

  • 11. The pivotal role of CXCL12 (SDF-1)/CXCR4 axis in bone metastasis.
    Wang J, Loberg R, Taichman RS.
    Cancer Metastasis Rev; 2006 Dec 20; 25(4):573-87. PubMed ID: 17165132
    [Abstract] [Full Text] [Related]

  • 12. Efficient one-pot synthesis of CXCL14 and its derivative using an N-sulfanylethylanilide peptide as a peptide thioester equivalent and their biological evaluation.
    Tsuji K, Tanegashima K, Sato K, Sakamoto K, Shigenaga A, Inokuma T, Hara T, Otaka A.
    Bioorg Med Chem; 2015 Sep 01; 23(17):5909-14. PubMed ID: 26187016
    [Abstract] [Full Text] [Related]

  • 13. The CXCL12-CXCR4 chemokine pathway: a novel axis regulates lymphangiogenesis.
    Zhuo W, Jia L, Song N, Lu XA, Ding Y, Wang X, Song X, Fu Y, Luo Y.
    Clin Cancer Res; 2012 Oct 01; 18(19):5387-98. PubMed ID: 22932666
    [Abstract] [Full Text] [Related]

  • 14. The chemokine CXCL14 mediates platelet function and migration via direct interaction with CXCR4.
    Witte A, Rohlfing AK, Dannenmann B, Dicenta V, Nasri M, Kolb K, Sudmann J, Castor T, Rath D, Borst O, Skokowa J, Gawaz M.
    Cardiovasc Res; 2021 Feb 22; 117(3):903-917. PubMed ID: 32239134
    [Abstract] [Full Text] [Related]

  • 15. Chemokine receptor CXCR4: role in gastrointestinal cancer.
    Lombardi L, Tavano F, Morelli F, Latiano TP, Di Sebastiano P, Maiello E.
    Crit Rev Oncol Hematol; 2013 Dec 22; 88(3):696-705. PubMed ID: 24120239
    [Abstract] [Full Text] [Related]

  • 16. CXCR4/CXCL12 axis promotes VEGF-mediated tumor angiogenesis through Akt signaling pathway.
    Liang Z, Brooks J, Willard M, Liang K, Yoon Y, Kang S, Shim H.
    Biochem Biophys Res Commun; 2007 Aug 03; 359(3):716-22. PubMed ID: 17559806
    [Abstract] [Full Text] [Related]

  • 17. CXCL14 Inhibits Insulin Secretion Independently of CXCR4 or CXCR7 Receptor Activation or cAMP Inhibition.
    Atanes P, Hawkes RG, Olaniru OE, Ruz-Maldonado I, Amisten S, Persaud SJ.
    Cell Physiol Biochem; 2019 Aug 03; 52(4):879-892. PubMed ID: 30958662
    [Abstract] [Full Text] [Related]

  • 18. LRRC4 inhibits human glioblastoma cells proliferation, invasion, and proMMP-2 activation by reducing SDF-1 alpha/CXCR4-mediated ERK1/2 and Akt signaling pathways.
    Wu M, Chen Q, Li D, Li X, Li X, Huang C, Tang Y, Zhou Y, Wang D, Tang K, Cao L, Shen S, Li G.
    J Cell Biochem; 2008 Jan 01; 103(1):245-55. PubMed ID: 17549698
    [Abstract] [Full Text] [Related]

  • 19. Phenotypic knockout of CXCR4 by a novel recombinant protein TAT/54R/KDEL inhibits tumors metastasis.
    Ma WF, Du J, Fu LP, Fang R, Chen HY, Cai SH.
    Mol Cancer Res; 2009 Oct 01; 7(10):1613-21. PubMed ID: 19825996
    [Abstract] [Full Text] [Related]

  • 20. The CXCR4/SDF-1 chemokine axis: a potential therapeutic target for bone metastases?
    Hirbe AC, Morgan EA, Weilbaecher KN.
    Curr Pharm Des; 2010 Oct 01; 16(11):1284-90. PubMed ID: 20166978
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.